131 related articles for article (PubMed ID: 1705762)
1. Iloprost for scleroderma.
Constans T; Diot E; Lasfargues G
Ann Intern Med; 1991 Apr; 114(7):606. PubMed ID: 1705762
[No Abstract] [Full Text] [Related]
2. Iloprost as cyclic five-day infusions in the treatment of scleroderma. An open pilot study in 20 patients treated for one year.
Biasi D; Carletto A; Caramaschi P; Zeminian S; Pacor ML; Corrocher R; Bambara LM
Rev Rhum Engl Ed; 1998 Dec; 65(12):745-50. PubMed ID: 9923042
[TBL] [Abstract][Full Text] [Related]
3. Digital ulcers in scleroderma patients: A retrospective observational study.
De Cata A; Inglese M; Molinaro F; De Cosmo S; Rubino R; Bernal M; Mazzoccoli G
Int J Immunopathol Pharmacol; 2016 Jun; 29(2):180-7. PubMed ID: 26684622
[TBL] [Abstract][Full Text] [Related]
4. [Iloprost for the treatment of systemic sclerosis].
Hachulla E; Launay D; Hatron PY
Presse Med; 2008 May; 37(5 Pt 2):831-9. PubMed ID: 18035518
[TBL] [Abstract][Full Text] [Related]
5. [Myocardial infarction and iloprost in a patient with scleroderma].
Marroun I; Fialip J; Deleveaux I; André M; Lamaison D; Cabane J; Piette JC; Eschalier A; Aumaitre O
Therapie; 2001; 56(5):630-2. PubMed ID: 11806306
[No Abstract] [Full Text] [Related]
6. Diffuse cutaneous systemic sclerosis treated with intravenous iloprost.
Foti C; Cassano N; Conserva A; Coviello C; De Meo M; Vena GA
Clin Exp Dermatol; 2004 May; 29(3):321-3. PubMed ID: 15115528
[No Abstract] [Full Text] [Related]
7. Photochemotherapy for systemic and localized scleroderma.
De Rie MA; Bos JD
J Am Acad Dermatol; 2000 Oct; 43(4):725-6. PubMed ID: 11004642
[No Abstract] [Full Text] [Related]
8. Iloprost treatment in systemic sclerosis: comment on the concise communication by Tedeschi et al.
Braun J; Sieper J; Riemekasten G; Hiepe F
Arthritis Rheum; 1999 Jan; 42(1):196-8. PubMed ID: 9920036
[No Abstract] [Full Text] [Related]
9. [Proteolytic enzyme, trypsin, in therapy of patients with scleroderma].
Dovzhanskiĭ SI; Slesarenko NA
Vestn Dermatol Venerol; 1977 Aug; (8):56-8. PubMed ID: 930311
[No Abstract] [Full Text] [Related]
10. [Madecassol in the treatment of scleroderma (preliminary study)].
Szczepański A; Dabrowska H; Blaszczyk M
Przegl Dermatol; 1974; 61(5):701-3. PubMed ID: 4419170
[No Abstract] [Full Text] [Related]
11. [Trafuril reaction in scleroderma].
Urban J
Przegl Dermatol; 1976; (6 Suppl):367-9. PubMed ID: 1032188
[No Abstract] [Full Text] [Related]
12. [General and local hormonal therapy in scleroderma].
Dobrescu A; Petrescu Z; Martinescu E; Costinescu M; Vasilca A; Popescu E; Rotaru L; Tăranu T; Pavelescu DM
Rev Med Chir Soc Med Nat Iasi; 1988; 92(1):145-9. PubMed ID: 3393746
[No Abstract] [Full Text] [Related]
13. [The course of scleroderma following treatment with carnitin].
Nitzschner H
Dermatol Monatsschr; 1974 Jul; 160(7):592-6. PubMed ID: 4411133
[No Abstract] [Full Text] [Related]
14. Thrombotic events in patients with systemic sclerosis treated with iloprost.
Tedeschi A; Meroni PL; Del Papa N; Salmaso C; Boschetti C; Miadonna A
Arthritis Rheum; 1998 Mar; 41(3):559-60. PubMed ID: 9506585
[No Abstract] [Full Text] [Related]
15. Oral calcitriol as a new therapeutic agent in localized and systemic scleroderma.
Humbert P; Aubin F; Dupond JL; Delaporte E
Arch Dermatol; 1995 Jul; 131(7):850-1. PubMed ID: 7611809
[No Abstract] [Full Text] [Related]
16. Effects of iloprost on microvascular structure assessed by nailfold videocapillaroscopy: a pilot study.
Shah P; Murray AK; Moore TL; Herrick AL
J Rheumatol; 2011 Sep; 38(9):2079-80. PubMed ID: 21885525
[No Abstract] [Full Text] [Related]
17. [Histomorphologic and histochemical changes in the skin during the treatment of scleroderma].
Sych LI; Trofimova LIa
Vestn Dermatol Venerol; 1971; 45(3):22-6. PubMed ID: 5122538
[No Abstract] [Full Text] [Related]
18. [Use of Tebessal in scleroderma].
Mattos O; de Oliveira Neto MP
Rev Bras Med; 1972 Mar; 29(3):139-40. PubMed ID: 5033154
[No Abstract] [Full Text] [Related]
19. Oral iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis: a multicenter, placebo-controlled, double-blind study.
Wigley FM; Korn JH; Csuka ME; Medsger TA; Rothfield NF; Ellman M; Martin R; Collier DH; Weinstein A; Furst DE; Jimenez SA; Mayes MD; Merkel PA; Gruber B; Kaufman L; Varga J; Bell P; Kern J; Marrott P; White B; Simms RW; Phillips AC; Seibold JR
Arthritis Rheum; 1998 Apr; 41(4):670-7. PubMed ID: 9550476
[TBL] [Abstract][Full Text] [Related]
20. Long-term clinical stabilization of scleroderma patients treated with a chronic and intensive IV iloprost regimen.
Foti R; Visalli E; Amato G; Benenati A; Converso G; Farina A; Bellofiore S; Mulè M; Di Gangi M
Rheumatol Int; 2017 Feb; 37(2):245-249. PubMed ID: 27796521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
